GW Cancer Center
Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.
Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.
A team at the GW Cancer Center will study the role of the COMPASS complex in the initiation and progression of pancreatic cancer.
The GW Cancer Center is pleased to welcome a team of internationally-recognized experts who together will lead the expanded Bone Marrow Transplant and Cell Therapies Program.
The GW Cancer Center is pleased to announce that Catherine Bollard, MD, has been appointed as the associate center director for translational research and innovation.
Sharad Goyal was recently selected to be a member of the NRG Oncology Developmental Therapeutics Radiation Therapy Subcommittee where he will spend the next two years working with members of the committee and the National Institutes of Health to bring new drugs to clinical trials.
A team from the GW Cancer Center received a 2018 Education Research Grant Award from the Center for Faculty Excellence at the GW School of Medicine and Health Sciences.
Research published in Cancer Cell by George Washington University (GW) Cancer Center researcher Alexandros Tzatsos, MD, PhD, found an important connection between the KDM6A gene and the most aggressive form of pancreatic cancer.
Researchers from the GW Cancer Center will participate and present posters at the AACR Annual Meeting held April 14-18.
The GW Cancer Center recently welcomed 24 multidisciplinary health care teams from across the country to its inaugural TEAM (Together, Equitable, Accessible, Meaningful) Training program.
